Debra B. Taylor, FNP

Debra Taylor practices at University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning.

Debra Taylor's NPI, 1326165218, was assigned on March 23, 2007. Debra Taylor holds Mississippi license 782722.

Debra Taylor's primary practice is University of Mississippi Medical Center, at 2500 N State St, Jackson, MS 39216 in Hinds County. The practice phone is (601) 984-4100.

Debra Taylor's primary practice is University of Mississippi Medical Center in Jackson, Mississippi, part of Mississippi Institutions of Higher Learning. The medical group on file is University of Mississippi Medical Center. Dmand AI also links Debra Taylor to 1 more behavioral health center, named with a free account. Debra Taylor's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Debra Taylor practices, 2 sites in all. Vendor and product names are available with a free account.

Family is Debra Taylor's primary specialty in the NPI Registry, under taxonomy code 363LF0000X. Debra Taylor is licensed in Mississippi.

CMS counts 98 Medicare patients who saw Debra Taylor in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have diabetes, and 75% have high blood pressure. 42% are also on Medicaid. Their average risk score is 2.63, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Debra Taylor's median patient age at 54, with 58% women.

In 2024, Debra Taylor wrote 2,471 Medicare Part D claims for 236 patients. 14% of them were for generic drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Debra Taylor for performance year 2024, reported as part of a group. Debra Taylor accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Debra Taylor as offering telehealth.

CMS Open Payments shows 4 general payments to Debra Taylor from 4 drug and device companies in 2025. Food and beverage make up the largest share, 100% of the total. Novo Nordisk Inc paid the most, $21.